Abstract

The present application describes a class of compounds exhibiting a coronavirus 3CL protease inhibitory effect and pharmaceutically acceptable salts thereof, and a pharmaceutical composition containing the same. The application also provides the synthesis of compounds and efficacy from in vitro and cell- based assays.

Keywords: Coronavirus-19, paxlovid, protease inhibitor, triazine derivatives, nidovirales, synthesis.